<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>732</volume><submitter>Murphy EJ</submitter><funding>Health Research Board</funding><pubmed_abstract>Coronavirus pneumonia is accompanied by rapid virus replication, where a large number of inflammatory cell infiltration and cytokine storm may lead to acute lung injury, acute respiratory distress syndrome (ARDS) and death. The uncontrolled release of pro-inflammatory cytokines, including interleukin (IL)-1β and IL-6, is associated with ARDS. This constituted the first study to report on the variability in physicochemical properties of β-glucans extracts from the same edible mushroom Lentinus edodes on the reduction of these pro-inflammatory cytokines and oxidative stress. Specifically, the impact on the immunomodulatory and cytoprotective properties of our novel in 'house' (IH-Lentinan, IHL) and a commercial (Carbosynth-Lentinan, CL) Lentinan extract were investigated using in vitro model</pubmed_abstract><journal>The Science of the total environment</journal><pagination>139330</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7211630</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>β-Glucan extracts from the same edible shiitake mushroom Lentinus edodes produce differential in-vitro immunomodulatory and pulmonary cytoprotective effects - Implications for coronavirus disease (COVID-19) immunotherapies.</pubmed_title><pmcid>PMC7211630</pmcid><pubmed_authors>Lynch M</pubmed_authors><pubmed_authors>Laffey JG</pubmed_authors><pubmed_authors>Masterson C</pubmed_authors><pubmed_authors>O'Toole D</pubmed_authors><pubmed_authors>Murphy EJ</pubmed_authors><pubmed_authors>Stack GD</pubmed_authors><pubmed_authors>Rowan NJ</pubmed_authors><pubmed_authors>Rezoagli E</pubmed_authors><pubmed_authors>Major I</pubmed_authors></additional><is_claimable>false</is_claimable><name>β-Glucan extracts from the same edible shiitake mushroom Lentinus edodes produce differential in-vitro immunomodulatory and pulmonary cytoprotective effects - Implications for coronavirus disease (COVID-19) immunotherapies.</name><description>Coronavirus pneumonia is accompanied by rapid virus replication, where a large number of inflammatory cell infiltration and cytokine storm may lead to acute lung injury, acute respiratory distress syndrome (ARDS) and death. The uncontrolled release of pro-inflammatory cytokines, including interleukin (IL)-1β and IL-6, is associated with ARDS. This constituted the first study to report on the variability in physicochemical properties of β-glucans extracts from the same edible mushroom Lentinus edodes on the reduction of these pro-inflammatory cytokines and oxidative stress. Specifically, the impact on the immunomodulatory and cytoprotective properties of our novel in 'house' (IH-Lentinan, IHL) and a commercial (Carbosynth-Lentinan, CL) Lentinan extract were investigated using in vitro model</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Aug</publication><modification>2026-05-02T05:07:19.865Z</modification><creation>2020-06-09T07:04:41Z</creation></dates><accession>S-EPMC7211630</accession><cross_references><pubmed>32413619</pubmed><doi>10.1016/j.scitotenv.2020.139330</doi></cross_references></HashMap>